Investigation of Insulin Resistance and Vitamin E Deficiency in Chronic Inflammatory Demyelinatıng Polyneuropathy: A 5‑year Retrospective Study

Gozke, Eren; TAŞTEKİN TOZ, Hilal

Investigation of Insulin Resistance and Vitamin E Deficiency in Chronic Inflammatory Demyelinatıng Polyneuropathy: A 5‑year Retrospective Study

Hilal TAŞTEKİN TOZ, (Sağlık Üniversitesi, Kartal Dr. Lütfi Kırdar Eğitim ve Araştırma Hastanesi, Nöroloji Bilimleri Anabilim Dalı, İstanbul, Türkiye)

Eren GÖZKE (Sağlık Bilimleri Üniversitesi, Fatih Sultan Mehmet Eğitim ve Araştırma Hastanesi, Nöroloji Bilimleri Anabilim Dalı, İstanbul, Türkiye)

Neurological sciences and neurophysiology (Online)

0 0

Yıl: 2020 Cilt: 37 Sayı: 1 Sayfa Aralığı: 24 - 28 Metin Dili: İngilizce İndeks Tarihi: 18-06-2021

Investigation of Insulin Resistance and Vitamin E Deficiency in Chronic Inflammatory Demyelinatıng Polyneuropathy: A 5‑year Retrospective Study

Öz:

Objective: Chronic inflammatory demyelinating polyneuropathy (CIDP) is atreatable disease; therefore, accurate diagnosis and detection of coexisting disordersare very important. Some authors have reported that CIDP was more frequentlyobserved in patients with diabetes mellitus when compared with the population ingeneral. Vitamin E deficiency leads to demyelinating neuropathy, and Vitamin Esupplementation ensures clinical and electrophysiological recovery. In this study,identifying the association between insulin resistance, Vitamin E deficiency, andCIDP is aimed. Materials and Methods: Thirty‑three patients with CIDP andforty healthy controls were evaluated. Two groups were compared in terms ofinsulin resistance and Vitamin E level status. Results: A statistically significantdifference was not found between CIDP and control groups as for the distributionof mean ages, genders, Homeostatic Model Assessment Index values, impairedfasting glucose, and a statistically significant difference was not found betweenCIDP and control groups as for Vitamin E deficiency. Conclusion: Our studycould not reveal any evidence about insulin resistance and Vitamin E deficiency inCIDP patients.

Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık

1. Lewis RA. Chronic inflammatory demyelinating polyneuropathy. Curr Opin Neurol 2017;30:508‑12.
2. Cornblath DR, Gorson KC, Hughes RA, Merkies IS. Observations on chronic inflammatory demyelinating polyneuropathy: A plea for a rigorous approach to diagnosis and treatment. J Neurol Sci 2013;330:2‑3.
3. Saperstein DS, Katz JS, Amato AA, Barohn RJ. Clinical spectrum of chronic acquired demyelinating polyneuropathies. Muscle Nerve 2001;24:311‑24.
4. Said G. Chronic inflammatory demyelinating polyneuropathy. Neuromuscul Disord 2006;16:293‑303.
5. Hughes RA, Bouche P, Cornblath DR, Evers E, Hadden RD, Hahn A, et al. European Federation of Neurological Societies/ Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. Eur J Neurol 2006;13:326-2.
6. Rentzos M, Anyfanti C, Kaponi A, Pandis D, Ioannou M, Vassilopoulos D. Chronic inflammatory demyelinating polyneuropathy: A 6‑year retrospective clinical study of a hospital‑based population. J Clin Neurosci 2007;14:229‑35.
7. Allen JA, Lewis RA. CIDP diagnostic pitfalls and perception of treatment benefit. Neurol 2015;85:498‑504.
8. Chiò A, Plano F, Calvo A, Leone M, Mutani R, Cocito D, et al. Comorbidity between CIDP and diabetes mellitus: Only a matter of chance? Eur J Neurol 2009;16:752‑4.
9. Fatehi F, Nafissi S, Basiri K, Amiri M, Soltanzadeh A. Chronic inflammatory demyelinating polyneuropathy associated with diabetes mellitus. J Res Med Sci 2013;18:438‑41.
10. Lotan I, Hellman MA, Steiner I. Diagnostic criteria of chronic inflammatory demyelinating polyneuropathy in diabetes mellitus. Acta Neurol Scand 2015;132:278‑83.
11. Dunnigan SK, Ebadi H, Breiner A, Katzberg HD, Barnett C, Perkins BA, et al. The characteristics of chronic inflammatory demyelinating polyneuropathy in patients with and without diabetes – An observational study. PLoS One 2014;9:e89344.
12. Laughlin RS, Dyck PJ, Melton LJ 3rd, Leibson C, Ransom J, Dyck PJ. Incidence and prevalence of CIDP and the association of diabetes mellitus. Neurol 2009;73:39‑45.
13. Dunnigan SK, Ebadi H, Breiner A, Katzberg HD, Lovblom LE, Perkins BA, et al. Comparison of diabetes patients with “demyelinating” diabetic sensorimotor polyneuropathy to those diagnosed with CIDP. Brain Behav 2013;3:656‑63.
14. Haq RU, Pendlebury WW, Fries TJ, Tandan R. Chronic inflammatory demyelinating polyradiculoneuropathy in diabetic patients. Muscle Nerve 2003;27:465‑70.
15. Sharma KR, Cross J, Farronay O, Ayyar DR, Shebert RT, Bradley WG. Demyelinating neuropathy in diabetes mellitus. Arch Neurol 2002;59:758‑65.
16. Lozeron P, Nahum L, Lacroix C, Ropert A, Guglielmi JM, series of 100 diabetic patients. J Neurol 2002;249:569‑75.
17. Chiò A, Cocito D, Bottacchi E, Buffa C, Leone M, Plano F, et al. Idiopathic chronic inflammatory demyelinating polyneuropathy: An epidemiological study in Italy. J Neurol Neurosurg Psychiatry 2007;78:1349‑53.
18. Abraham A, Albulaihe H, Alabdali M, Qrimli M, Breiner A, Barnett C, et al. Frequent laboratory abnormalities in CIDP patients. Muscle Nerve 2016;53:862‑5.
19. Sumner CJ, Sheth S, Griffin JW, Cornblath DR, Polydefkis M. The spectrum of neuropathy in diabetes and impaired glucose tolerance. Neurol 2003;60:108‑11.
20. Farhad K, Traub R, Ruzhansky KM, Brannagan TH 3rd. Causes of neuropathy in patients referred as “idiopathic neuropathy”. Muscle Nerve 2016;53:856‑61.
21. Singleton JR, Smith AG, Bromberg MB. Painful sensory polyneuropathy associated with impaired glucose tolerance. Muscle Nerve 2001;24:1225‑8.
22. Smith AG, Singleton JR. Impaired glucose tolerance and neuropathy. Neurol 2008;14:23‑9.
23. Singleton JR, Smith AG, Bromberg MB. Increased prevalence of impaired glucose tolerance in patients with painful sensory neuropathy. Diabetes Care 2001;24:1448‑53.
24. Ince H, Taşdemir HA, Aydin M, Ozyürek H, Tilki HE. Evaluation of nerve conduction studies in obese children with insulin resistance or impaired glucose tolerance. J Child Neurol 2015;30:989‑99.
25. Puri V, Chaudhry N, Tatke M, Prakash V. Isolated vitamin E deficiency with demyelinating neuropathy. Muscle Nerve 2005;32:230‑5.
26. Cecchini T, Cuppini R, Ciaroni S, Del Grande P. Effect of vitamin E‑deficiency on regeneration of the sciatic nerve. Arch Ital Anat Embriol 1990;95:155‑65.
27. Mayer‑Davis EJ, Costacou T, King I, Zaccaro DJ, Bell RA; Insulin Resistance and Atherosclerosis Study (IRAS). Plasma and dietary vitamin E in relation to incidence of type 2 diabetes: The Insulin resistance and atherosclerosis study (IRAS). Diabetes Care 2002;25:2172‑7.

APA	TAŞTEKİN TOZ H, Gozke E (2020). Investigation of Insulin Resistance and Vitamin E Deficiency in Chronic Inflammatory Demyelinatıng Polyneuropathy: A 5‑year Retrospective Study. , 24 - 28.
Chicago	TAŞTEKİN TOZ Hilal,Gozke Eren Investigation of Insulin Resistance and Vitamin E Deficiency in Chronic Inflammatory Demyelinatıng Polyneuropathy: A 5‑year Retrospective Study. (2020): 24 - 28.
MLA	TAŞTEKİN TOZ Hilal,Gozke Eren Investigation of Insulin Resistance and Vitamin E Deficiency in Chronic Inflammatory Demyelinatıng Polyneuropathy: A 5‑year Retrospective Study. , 2020, ss.24 - 28.
AMA	TAŞTEKİN TOZ H,Gozke E Investigation of Insulin Resistance and Vitamin E Deficiency in Chronic Inflammatory Demyelinatıng Polyneuropathy: A 5‑year Retrospective Study. . 2020; 24 - 28.
Vancouver	TAŞTEKİN TOZ H,Gozke E Investigation of Insulin Resistance and Vitamin E Deficiency in Chronic Inflammatory Demyelinatıng Polyneuropathy: A 5‑year Retrospective Study. . 2020; 24 - 28.
IEEE	TAŞTEKİN TOZ H,Gozke E "Investigation of Insulin Resistance and Vitamin E Deficiency in Chronic Inflammatory Demyelinatıng Polyneuropathy: A 5‑year Retrospective Study." , ss.24 - 28, 2020.
ISNAD	TAŞTEKİN TOZ, Hilal - Gozke, Eren. "Investigation of Insulin Resistance and Vitamin E Deficiency in Chronic Inflammatory Demyelinatıng Polyneuropathy: A 5‑year Retrospective Study". (2020), 24-28.

APA	TAŞTEKİN TOZ H, Gozke E (2020). Investigation of Insulin Resistance and Vitamin E Deficiency in Chronic Inflammatory Demyelinatıng Polyneuropathy: A 5‑year Retrospective Study. Neurological sciences and neurophysiology (Online), 37(1), 24 - 28.
Chicago	TAŞTEKİN TOZ Hilal,Gozke Eren Investigation of Insulin Resistance and Vitamin E Deficiency in Chronic Inflammatory Demyelinatıng Polyneuropathy: A 5‑year Retrospective Study. Neurological sciences and neurophysiology (Online) 37, no.1 (2020): 24 - 28.
MLA	TAŞTEKİN TOZ Hilal,Gozke Eren Investigation of Insulin Resistance and Vitamin E Deficiency in Chronic Inflammatory Demyelinatıng Polyneuropathy: A 5‑year Retrospective Study. Neurological sciences and neurophysiology (Online), vol.37, no.1, 2020, ss.24 - 28.
AMA	TAŞTEKİN TOZ H,Gozke E Investigation of Insulin Resistance and Vitamin E Deficiency in Chronic Inflammatory Demyelinatıng Polyneuropathy: A 5‑year Retrospective Study. Neurological sciences and neurophysiology (Online). 2020; 37(1): 24 - 28.
Vancouver	TAŞTEKİN TOZ H,Gozke E Investigation of Insulin Resistance and Vitamin E Deficiency in Chronic Inflammatory Demyelinatıng Polyneuropathy: A 5‑year Retrospective Study. Neurological sciences and neurophysiology (Online). 2020; 37(1): 24 - 28.
IEEE	TAŞTEKİN TOZ H,Gozke E "Investigation of Insulin Resistance and Vitamin E Deficiency in Chronic Inflammatory Demyelinatıng Polyneuropathy: A 5‑year Retrospective Study." Neurological sciences and neurophysiology (Online), 37, ss.24 - 28, 2020.
ISNAD	TAŞTEKİN TOZ, Hilal - Gozke, Eren. "Investigation of Insulin Resistance and Vitamin E Deficiency in Chronic Inflammatory Demyelinatıng Polyneuropathy: A 5‑year Retrospective Study". Neurological sciences and neurophysiology (Online) 37/1 (2020), 24-28.